Skip to main content
Have a personal or library account? Click to login
Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance Cover

Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance

Open Access
|Sep 2019

Authors

Julie Redfern

julie.redfern@sydney.edu.au

Faculty of Medicine and Health, Westmead Applied Research Centre, University of Sydney, Sydney

Harparkash Kaur

info@ubiquitypress.com

Department of Clinical Research, London School of Hygiene and Tropical Medicine, London

Rufus Adesoji Adedoyin

info@ubiquitypress.com

Department of Medical Rehabilitation, College of Health Sciences, Obafemi Awolowo University, Ile-Ife

Sandra Ofori

info@ubiquitypress.com

Department of Internal Medicine, University of Port Harcourt Teaching Hospital, University of Port Harcourt, Port Harcourt

Raghupathy Anchala

info@ubiquitypress.com

Chest Research Foundation, Pune

Ajay S. Vamadevan

info@ubiquitypress.com

Public Health Foundation of India, Gurgaon

Luciano De Andrade

info@ubiquitypress.com

Department of Medicine, State University of Maringa, Maringá

Jose Zelaya

info@ubiquitypress.com

Peruvian Society of Hypertension, Lima

Dina Balabanova

info@ubiquitypress.com

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London

Mahmoud Umar Sani

info@ubiquitypress.com

Department of Medicine, Bayero University Kano and Aminu Kano Teaching Hospital; PMB 3452, Kano
Language: English
Published on: Sep 1, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Julie Redfern, Harparkash Kaur, Rufus Adesoji Adedoyin, Sandra Ofori, Raghupathy Anchala, Ajay S. Vamadevan, Luciano De Andrade, Jose Zelaya, Dina Balabanova, Mahmoud Umar Sani, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.